Literature DB >> 22347990

Inborn errors of anti-viral interferon immunity in humans.

Vanessa Sancho-Shimizu1, Rebeca Perez de Diego, Emmanuelle Jouanguy, Shen-Ying Zhang, Jean-Laurent Casanova.   

Abstract

The three types of interferon (IFNs) are essential for immunity against at least some viruses in the mouse model of experimental infections, type I IFNs displaying the broadest and strongest anti-viral activity. Consistently, human genetic studies have shown that type II IFN is largely redundant for immunity against viruses in the course of natural infections. The precise contributions of human type I and III IFNs remain undefined. However, various inborn errors of anti-viral IFN immunity have been described, which can result in either broad or narrow immunological and viral phenotypes. The broad disorders impair the response to (STAT1, TYK2) or the production of at least type I and type III IFNs following multiple stimuli (NEMO), resulting in multiple viral infections at various sites, including herpes simplex encephalitis (HSE). The narrow disorders impair exclusively (TLR3) or mostly (UNC-93B, TRIF, TRAF3) the TLR3-dependent induction of type I and III IFNs, leading to HSE in apparently otherwise healthy individuals. These recent discoveries highlight the importance of human type I and III IFNs in protective immunity against viruses, including the TLR3-IFN pathway in protection against HSE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22347990      PMCID: PMC3280408          DOI: 10.1016/j.coviro.2011.10.016

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  124 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 2.  Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?

Authors:  Alexandre Alcaïs; Lluis Quintana-Murci; David S Thaler; Erwin Schurr; Laurent Abel; Jean-Laurent Casanova
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

3.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

Review 4.  Toll-like receptors in CNS viral infections.

Authors:  Hyeon-Sook Suh; Celia F Brosnan; Sunhee C Lee
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

5.  A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA.

Authors:  Myoung Kwon Choi; ZhiChao Wang; Tatsuma Ban; Hideyuki Yanai; Yan Lu; Ryuji Koshiba; Yukana Nakaima; Sho Hangai; David Savitsky; Makoto Nakasato; Hideo Negishi; Osamu Takeuchi; Kenya Honda; Shizuo Akira; Tomohiko Tamura; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-01       Impact factor: 11.205

6.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

7.  DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling.

Authors:  Moeko Miyashita; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

Review 8.  The role played by natural selection on Mendelian traits in humans.

Authors:  Lluis Quintana-Murci; Luis B Barreiro
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

9.  Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation.

Authors:  Donatella Vairo; Laura Tassone; Giovanna Tabellini; Nicola Tamassia; Sara Gasperini; Flavia Bazzoni; Alessandro Plebani; Fulvio Porta; Luigi D Notarangelo; Silvia Parolini; Silvia Giliani; Raffaele Badolato
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

10.  X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Margje H Haverkamp; Emilie Vinolo; Cheng-Lung Ku; Anne Puel; David M Frucht; Karin Christel; Horst von Bernuth; Emmanuelle Jouanguy; Jacqueline Feinberg; Anne Durandy; Brigitte Senechal; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Claire Fieschi; Capucine Picard; Meriem Garfa; Jalel Chemli; Mohamed Bejaoui; Maria N Tsolia; Necil Kutukculer; Alessandro Plebani; Luigi Notarangelo; Christine Bodemer; Frédéric Geissmann; Alain Israël; Michel Véron; Maike Knackstedt; Ridha Barbouche; Laurent Abel; Klaus Magdorf; Dominique Gendrel; Fabrice Agou; Steven M Holland; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  67 in total

1.  Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

Authors:  Yong Zhang; Dailing Mao; Shamus P Keeler; Xinyu Wang; Kangyun Wu; Benjamin J Gerovac; Laurie L Shornick; Eugene V Agapov; Michael J Holtzman
Journal:  J Immunol       Date:  2019-02-25       Impact factor: 5.422

Review 2.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

Review 3.  The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.

Authors:  Daniel Giraldo; Douglas R Wilcox; Richard Longnecker
Journal:  DNA Cell Biol       Date:  2017-03-09       Impact factor: 3.311

Review 4.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

Review 5.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

Review 6.  Generating protective immunity against genital herpes.

Authors:  Haina Shin; Akiko Iwasaki
Journal:  Trends Immunol       Date:  2013-09-03       Impact factor: 16.687

7.  Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression.

Authors:  Marguerite Kreit; Sophie Paul; Laurent Knoops; Aurélie De Cock; Frédéric Sorgeloos; Thomas Michiels
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

8.  The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin.

Authors:  Benjamin N Gantner; Huali Jin; Feng Qian; Nissim Hay; Bin He; Richard D Ye
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

9.  TCR independent suppression of CD8(+) T cell cytokine production mediated by IFNγ in vivo.

Authors:  Martin P Hosking; Claudia T Flynn; J Lindsay Whitton
Journal:  Virology       Date:  2016-08-24       Impact factor: 3.616

10.  Herpes Simplex Virus 1 Interaction with Myeloid Cells In Vivo.

Authors:  Maitreyi Shivkumar; Clara Lawler; Ricardo Milho; Philip G Stevenson
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.